Combined Impact of Omicron Vaccination and Environmental Risk Exposure: A Thailand Case Study

Combined Impact of Omicron Vaccination and Environmental Risk Exposure: A Thailand Case Study

This research aimed to determine the levels of COVID-19 booster dose vaccinations in Thai populations in areas with environmental risk exposure during the Omicron outbreak. Five of twenty provinces in Thailand were selected by assessing environmental risk exposure for study settings. A total of 1038...

Full description

Bibliographic Details
Main Authors:	Weerawat Ounsaneha, Orapin Laosee, Thunwadee Tachapattaworakul Suksaroj, Cheerawit Rattanapan
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Vaccines
Subjects:	COVID-19 booster dose environmental risk exposure Omicron variants
Online Access:	https://www.mdpi.com/2076-393X/11/2/297

Similar Items

Health Risk Assessment from Haloacetic Acids Exposure in Indoor and Outdoor Swimming Pool Water
by: Weerawat Ounsanaeha, et al.
Published: (2017-07-01)

Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
by: Vivek P. Chavda, et al.
Published: (2022-02-01)

The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
by: Ka-Wa Khong, et al.
Published: (2022-11-01)

Inactivated COVID-19 vaccine booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2
by: Jun Wu, et al.
Published: (2023-06-01)

The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
by: Yuntao Zou, et al.
Published: (2022-07-01)

Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
by: Barbara Grüne, et al.
Published: (2022-06-01)

Health Risk Assessment of Hydrogen Sulfide Exposure among Workers in a Thai Rubber Latex Industry
by: Cheerawit Rattanapan, et al.
Published: (2014-01-01)

Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice
by: Jianyang Liu, et al.
Published: (2023-12-01)

A New Chapter in the COVID-19 Pandemic: the Characteristics of Omicron Variant and A New Step for Scientific Epidemic Prevention and Control
by: LI Yi, et al.
Published: (2023-01-01)

Real-world effectiveness of full and booster mRNA vaccination for coronavirus disease 2019 against disease severity during the delta- and omicron-dominant phases: A propensity score-matched cohort study using the nationwide registry data in Japan
by: Tetsuya Suzuki, et al.
Published: (2024-02-01)

Real-World Effectiveness of a Booster Dose of the COVID-19 Vaccines among Japanese University Students
by: Shunsuke Miyauchi, et al.
Published: (2022-08-01)

Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand
by: Karan Thakkar, et al.
Published: (2023-12-01)

Interactive effect of booster vaccination and vitamin D status on antibody production of Omicron variant‐infected adults: A real‐world cohort study
by: Denggao Peng, et al.
Published: (2023-10-01)

Vaccine Confidence and Uptake of the Omicron Bivalent Booster in Tennessee: Implications for Vulnerable Populations
by: Donald J. Alcendor, et al.
Published: (2023-04-01)

Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies
by: Shangchen Song, et al.
Published: (2023-06-01)

Promoting Circular Economy in the Palm Oil Industry through Biogas Codigestion of Palm Oil Mill Effluent and Empty Fruit Bunch Pressed Wastewater
by: Chaisri Suksaroj, et al.
Published: (2023-06-01)

Removal of Hydrogen Sulfide Gas using Biofiltration - a Review
by: Cheerawit RATTANAPAN, et al.
Published: (2011-11-01)

Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study
by: Xiaofeng He, et al.
Published: (2023-10-01)

Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update
by: Ranjan K. Mohapatra, et al.
Published: (2022-11-01)

Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients
by: Lei Zhang, et al.
Published: (2023-01-01)

COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
by: Dorota Zarębska-Michaluk, et al.
Published: (2022-07-01)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
by: Shohei Yamamoto, et al.
Published: (2023-05-01)

A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants
by: Joy-Yan Lam, et al.
Published: (2022-12-01)

The importance of booster vaccination in the context of Omicron wave
by: Zichun Wei, et al.
Published: (2022-09-01)

Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants
by: Liqiu Jia, et al.
Published: (2022-07-01)

Modeling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Malaysia
by: Karan Thakkar, et al.
Published: (2023-12-01)

Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
by: Milja Belik, et al.
Published: (2023-01-01)

Effectiveness of mRNA Vaccine Booster against SARS-CoV-2 Infection and COVID-19 in the Adult Population during the First Three Months of the Omicron Wave in Sicily
by: Giuseppe Vella, et al.
Published: (2023-01-01)

Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Omicron Variant (B.1.1.529): A Systematic Review with Meta-Analysis and Meta-Regression
by: Nando Reza Pratama, et al.
Published: (2022-12-01)

Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational studyResearch in context
by: Ralf Duerr, et al.
Published: (2023-11-01)

Relative effectiveness of bivalent COVID-19 vaccine: a systematic review and meta-analysis
by: Meng-qun Cheng, et al.
Published: (2024-02-01)

Effectiveness of Mix-and-Match Vaccination in Preventing SARS-CoV-2 Omicron Variant Infection in Taiwan: A Test-Negative Control Study
by: Yu-Tung Huang, et al.
Published: (2023-08-01)

COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents
by: David H. Canaday, et al.
Published: (2022-06-01)

Immunogenicity against the Omicron Variant after mRNA-Based COVID-19 Booster Vaccination in Medical Students Who Received Two Primary Doses of the mRNA-1273 Vaccine
by: Hyemin Chung, et al.
Published: (2022-12-01)

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adultsResearch in context
by: Constanza Méndez, et al.
Published: (2023-05-01)

The Difference in Wave Dynamics between SARS-CoV-2 Pre-Omicron and Omicron Variant Waves
by: Franz Konstantin Fuss, et al.
Published: (2022-12-01)

Levels and durability of neutralizing antibodies against SARS-CoV-2 Omicron and other variants after ChAdOx-1 or BNT162b2 booster in CoronaVac-primed elderly individuals
by: Nuchjira Takheaw, et al.
Published: (2023-04-01)

Effect of second booster vaccination on clinical outcomes of Omicron-variant breakthrough infection: A propensity score matching cohort study
by: Denggao Peng, et al.
Published: (2024-01-01)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
by: Tao Li, et al.
Published: (2023-12-01)

Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies
by: Abundio Balgos, et al.
Published: (2024-12-01)